Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMolla, Meritxell
dc.contributor.authorFernandez-Plana, Julen
dc.contributor.authorAlbiol, Santiago
dc.contributor.authorFondevila, Constantino
dc.contributor.authorVollmer, Ivan
dc.contributor.authorCases, Carla
dc.contributor.authorCapdevila Castillon, Jaume
dc.date.accessioned2022-01-13T17:37:37Z
dc.date.available2022-01-13T17:37:37Z
dc.date.issued2021-05
dc.identifier.citationMolla M, Fernandez-Plana J, Albiol S, Fondevila C, Vollmer I, Cases C, et al. Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT. J Clin Med. 2021 May;10(10):2131.
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/11351/6794
dc.descriptionAblation; Colorectal cancer; Liver metastases
dc.description.abstractThe prognosis for oligometastatic colorectal cancer has improved in recent years, mostly because of recent advances in new techniques and approaches to the treatment of oligometastases, including new surgical procedures, better systemic treatments, percutaneous ablation, and stereotactic body radiation therapy (SBRT). There are several factors to consider when deciding on the better approach for each patient: tumor factors (metachronous or synchronous metastases, RAS mutation, BRAF mutation, disease-free interval, size and number of metastases), patient factors (age, frailty, comorbidities, patient preferences), and physicians’ factors (local expertise). These advances have presented major challenges and opportunities for oncologic multidisciplinary teams to treat patients with limited liver and lung metastases from colorectal cancer with a curative intention. In this review, we describe the different treatment options in patients with limited liver and lung metastases from colorectal cancer, and the possible combination of three approaches: systemic treatment, surgery, and local ablative treatments.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesJournal of Clinical Medicine;10(10)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCòlon - Càncer - Tractament
dc.subjectRecte - Càncer - Tractament
dc.subjectMetàstasi
dc.subject.meshColorectal Neoplasms
dc.subject.mesh/therapy
dc.subject.meshNeoplasm Metastasis
dc.titleLimited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/jcm10102131
dc.subject.decsneoplasias colorrectales
dc.subject.decs/terapia
dc.subject.decsmetástasis neoplásica
dc.relation.publishversionhttps://doi.org/10.3390/jcm10102131
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Molla M] Department of Radiation Oncology, Hospital Clinic Barcelona, Barcelona 08036, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona 08036, Spain. [Fernandez-Plana J] Department of Medical Oncology, Hospital Mutua de Terrassa, Terrassa 08221, Spain. [Albiol S] Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona 08036, Spain. [Fondevila C] Department of General and Digestive Surgery, Hospital Clinic de Barcelona, Barcelona 08036, Spain. [Vollmer I] Department of Radiology, Hospital Clinic Barcelona, Barcelona 08036, Spain. [Cases C] Department of Radiation Oncology, Hospital Clinic Barcelona, Barcelona 08036, Spain. [Capdevila J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid34069240
dc.identifier.wos000654877600001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record